Audrey L. Shaw

3.1k total citations · 2 hit papers
34 papers, 2.3k citations indexed

About

Audrey L. Shaw is a scholar working on Gastroenterology, Genetics and Epidemiology. According to data from OpenAlex, Audrey L. Shaw has authored 34 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Gastroenterology, 10 papers in Genetics and 8 papers in Epidemiology. Recurrent topics in Audrey L. Shaw's work include Gastrointestinal motility and disorders (10 papers), Inflammatory Bowel Disease (7 papers) and Celiac Disease Research and Management (7 papers). Audrey L. Shaw is often cited by papers focused on Gastrointestinal motility and disorders (10 papers), Inflammatory Bowel Disease (7 papers) and Celiac Disease Research and Management (7 papers). Audrey L. Shaw collaborates with scholars based in United States, South Africa and Canada. Audrey L. Shaw's co-authors include William P. Forbes, Enoch Bortey, Shadreck M. Mareya, Anthony Lembo, Mark Pimentel, Jing Yu, Salam Zakko, Yehuda Ringel, William D. Chey and Shirley Huang and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Audrey L. Shaw

31 papers receiving 2.2k citations

Hit Papers

Rifaximin Treatment in Hepatic Encephalopathy 2010 2026 2015 2020 2010 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rifaximin Treatment in Hepatic Encephalopathy
    2010 848 citations Nathan M. Bass, Kevin D. Mullen et al. New England Journal of Medicine profile →
  2. Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
    2011 720 citations Mark Pimentel, Anthony Lembo et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Audrey L. Shaw United States 13 912 771 769 753 412 34 2.3k
Anton LeMair Canada 13 800 0.9× 957 1.2× 139 0.2× 677 0.9× 332 0.8× 15 2.6k
K. Gyr Switzerland 33 851 0.9× 1.5k 1.9× 279 0.4× 688 0.9× 212 0.5× 110 3.2k
Shahab Abid Pakistan 24 628 0.7× 880 1.1× 614 0.8× 513 0.7× 127 0.3× 107 1.8k
Theodore Hersh United States 29 553 0.6× 1.1k 1.4× 326 0.4× 584 0.8× 145 0.4× 79 2.4k
Nicole A. Noble United States 16 2.3k 2.5× 921 1.2× 2.0k 2.5× 212 0.3× 367 0.9× 21 3.6k
Pamela Monteith United States 9 1.5k 1.6× 521 0.7× 1.1k 1.4× 154 0.2× 315 0.8× 10 2.5k
Marion Aw Singapore 20 386 0.4× 475 0.6× 433 0.6× 77 0.1× 149 0.4× 110 1.6k
Chathur Acharya United States 24 1.3k 1.4× 823 1.1× 836 1.1× 129 0.2× 239 0.6× 61 2.2k
Philip Abraham India 22 369 0.4× 685 0.9× 238 0.3× 305 0.4× 297 0.7× 99 1.6k
Shobna Bhatia India 22 377 0.4× 816 1.1× 360 0.5× 524 0.7× 66 0.2× 78 1.5k

Countries citing papers authored by Audrey L. Shaw

Since Specialization
Citations

This map shows the geographic impact of Audrey L. Shaw's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Audrey L. Shaw with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Audrey L. Shaw more than expected).

Fields of papers citing papers by Audrey L. Shaw

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Audrey L. Shaw. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Audrey L. Shaw. The network helps show where Audrey L. Shaw may publish in the future.

Co-authorship network of co-authors of Audrey L. Shaw

This figure shows the co-authorship network connecting the top 25 collaborators of Audrey L. Shaw. A scholar is included among the top collaborators of Audrey L. Shaw based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Audrey L. Shaw. Audrey L. Shaw is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Utay, Netanya S., Anoma Somasunderam, John E. Hinkle, et al.. (2019). Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART. SHILAP Revista de lepidopterología. 4(1). 124–124. 9 indexed citations
2.
Shaw, Audrey L., et al.. (2017). Impact of serum-derived bovine immunoglobulin/protein isolate therapy on irritable bowel syndrome and inflammatory bowel disease: a survey of patient perspective. Patient Preference and Adherence. Volume 11. 1001–1007. 16 indexed citations
3.
4.
Valentin, Nelson, Michael Camilleri, Paula Carlson, et al.. (2017). Potential mechanisms of effects of serum‐derived bovine immunoglobulin/protein isolate therapy in patients with diarrhea‐predominant irritable bowel syndrome. Physiological Reports. 5(5). 22 indexed citations
5.
Weaver, Eric, et al.. (2016). Unique Post‐Prandial Amino Acid Responses Following Oral Administration of Serum‐Derived Bovine Immunoglobulin. The FASEB Journal. 30(S1). 1 indexed citations
6.
Shaw, Audrey L., John E. Hinkle, Bryon W. Petschow, et al.. (2016). Absorption and safety of serum-derived bovine immunoglobulin/protein isolate in healthy adults. Clinical and Experimental Gastroenterology. Volume 9. 365–375. 11 indexed citations
7.
Petschow, Bryon W., Bruce Burnett, Audrey L. Shaw, Eric Weaver, & Gerald L. Klein. (2014). Serum-derived bovine immunoglobulin/ protein isolate: postulated mechanism of action for management of enteropathy. Clinical and Experimental Gastroenterology. 7. 181–181. 31 indexed citations
8.
Petschow, Bryon W., Bruce Burnett, Audrey L. Shaw, Eric Weaver, & Gerald L. Klein. (2014). Dietary Requirement for Serum-Derived Bovine Immunoglobulins in the Clinical Management of Patients with Enteropathy. Digestive Diseases and Sciences. 60(1). 13–23. 21 indexed citations
9.
Klein, Gerald L., Bryon W. Petschow, Audrey L. Shaw, & Eric Weaver. (2013). Gut barrier dysfunction and microbial translocation in cancer cachexia. Current Opinion in Supportive and Palliative Care. 7(4). 361–367. 77 indexed citations
10.
Shaw, Audrey L.. (2013). Does Laughter Therapy Improve Symptoms of Depression among the Elderly Population. Digital Commons - PCOM (Philadelphia College of Osteopathic Medicine). 1 indexed citations
11.
Pimentel, Mark, Anthony Lembo, William D. Chey, et al.. (2011). Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation. New England Journal of Medicine. 364(1). 22–32. 720 indexed citations breakdown →
12.
13.
Martinez‐Sandoval, Francisco, Charles D. Ericsson, Zhi‐Dong Jiang, et al.. (2010). Prevention of Travelers' Diarrhea With Rifaximin in US Travelers to Mexico. Journal of Travel Medicine. 17(2). 111–117. 29 indexed citations
14.
Bass, Nathan M., Kevin D. Mullen, Arun J. Sanyal, et al.. (2010). Rifaximin Treatment in Hepatic Encephalopathy. New England Journal of Medicine. 362(12). 1071–1081. 848 indexed citations breakdown →
15.
16.
Scherl, Ellen, Ronald E. Pruitt, Glenn L. Gordon, et al.. (2009). Safety and Efficacy of a New 3.3 g b.i.d. Tablet Formulation in Patients With Mild-to-Moderately-Active Ulcerative Colitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. The American Journal of Gastroenterology. 104(6). 1452–1459. 41 indexed citations
17.
18.
Lichtenstein, Gary R., et al.. (2008). Once-Daily 1.5-G Granulated mesalamine Effectively Maintains Remission in Patients with Ulcerative Colitis Who Switch from Different 5-ASA Formulations. The American Journal of Gastroenterology. 103. S429–S430. 2 indexed citations
19.
Haas, David W., John Bartlett, Janet W. Andersen, et al.. (2006). Pharmacogenetics of Nevirapine-Associated Hepatotoxicity: An Adult AIDS Clinical Trials Group Collaboration. Clinical Infectious Diseases. 43(6). 783–786. 105 indexed citations
20.
Sanne, Ian, Herve Momméja-Marin, John E. Hinkle, et al.. (2005). Severe Hepatotoxicity Associated with Nevirapine Use in HIV‐Infected Subjects. The Journal of Infectious Diseases. 191(6). 825–829. 195 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anton LeMair Breakdown of academic impact, for papers by K. Gyr Breakdown of academic impact, for papers by Shahab Abid Breakdown of academic impact, for papers by Theodore Hersh Breakdown of academic impact, for papers by Nicole A. Noble Breakdown of academic impact, for papers by Pamela Monteith Breakdown of academic impact, for papers by Marion Aw Breakdown of academic impact, for papers by Chathur Acharya Breakdown of academic impact, for papers by Philip Abraham Breakdown of academic impact, for papers by Shobna Bhatia
Rankless by CCL
2026